Direkt zum Inhalt
Merck

Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4.

Bioorganic & medicinal chemistry letters (2006-03-28)
Jay P Powers, Shyun Li, Juan C Jaen, Jinqian Liu, Nigel P C Walker, Zhulun Wang, Holger Wesche
ZUSAMMENFASSUNG

High-throughput screening of a small-molecule compound library resulted in the identification of a novel series of N-acyl 2-aminobenzimidazoles that are potent inhibitors of interleukin-1 receptor-associated kinase-4.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
IRAK-1/4 Inhibitor I, ≥98% (HPLC), solid
Sigma-Aldrich
Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor, InSolution, ≥98%